Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Trial of Oral VXA-CoV2-1.1-S Vaccine for COVID-19
NCT05067933Phase 2Terminated
- Sponsor
- Vaxart, Inc.
- Start
- Oct 2021
- Primary completion
- Jun 2022
- Modality
- Drug Delivery Systems, Vaccines & Immunotherapeutics, Viral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of VXA-CoV2-1.1-S in coronavirus disease 2019 (COVID-19), sponsored by Vaxart, Inc.. Started Oct 2021; status: terminated.
02
Drugs
VXA-CoV2-1.1-S
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05067933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05067933.